These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21093105)

  • 1. [Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%].
    Alalwani H; Omer Saleh B; Rocher N; Renard G; Bourges JL; Legeais JM
    J Fr Ophtalmol; 2010 Dec; 33(10):710-4. PubMed ID: 21093105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
    Unal M; Yücel I
    Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third or greater penetrating keratoplasties: indications, survival, and visual outcomes.
    Yildiz EH; Hoskins E; Fram N; Rapuano CJ; Hammersmith KM; Laibson PR; Cohen EJ
    Cornea; 2010 Mar; 29(3):254-9. PubMed ID: 20118784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
    Javadi MA; Feizi S; Karbasian A; Rastegarpour A
    Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.
    Shimazaki J; Den S; Omoto M; Satake Y; Shimmura S; Tsubota K
    Am J Ophthalmol; 2011 Jul; 152(1):33-39.e1. PubMed ID: 21570054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
    Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
    J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A in perforating keratoplasty.
    Sundmacher R; Reinhard T
    Cesk Slov Oftalmol; 1995 Oct; 51(5):271-6. PubMed ID: 8948156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases].
    Robert PY; Delbosc B; Preux PM; Monnot PH; Drouet M; Peyronnet P; Adenis JP
    J Fr Ophtalmol; 1997; 20(7):507-14. PubMed ID: 9499974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.
    Sinha R; Jhanji V; Verma K; Sharma N; Biswas NR; Vajpayee RB
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1167-72. PubMed ID: 20414783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical cyclosporin: a treatment for corneal graft rejection.
    Ross AH; Cook SD
    Clin Exp Ophthalmol; 2008 Jul; 36(5):399-400. PubMed ID: 18925911
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical cyclosporine.
    Sinha R; Vishnu S; Sharma N; Vajpayee RB
    Ophthalmology; 2009 Oct; 116(10):2038-38.e1. PubMed ID: 19800526
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical cyclosporine in corneal transplantation.
    Ziaei M; Manzouri B
    Cornea; 2015 Jan; 34(1):110-5. PubMed ID: 25357076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].
    Kasparov AA; Aladinskaia IV
    Vestn Oftalmol; 2002; 118(4):16-8. PubMed ID: 12371314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty].
    Nguyen NX; Seitz B; Langenbucher A; Wenkel H; Cursiefen C
    Klin Monbl Augenheilkd; 2004 Jun; 221(6):467-72. PubMed ID: 15236106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cyclosporin A in the management of postkeratoplasty glaucoma.
    Perry HD; Donnenfeld ED; Kanellopoulos AJ; Grossman GA
    Cornea; 1997 May; 16(3):284-8. PubMed ID: 9143799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.